Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-18
2005-01-18
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S556000
Reexamination Certificate
active
06844337
ABSTRACT:
Compounds corresponding to general formula (I)in which R1, R2, R3, R4and R5each represent, independently of one another, a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, trifluoromethoxy, cyano, hydroxy, (C1-C6)alkyl, (C1-C6)alkoxy or phenyl group, it also being possible for two of these substituents in adjacent positions together to represent a methylenedioxy group, and R6represents a hydrogen atom or a (C1-C6)alkyl group.Application in therapeutics.
REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 0307140 (1989-03-01), None
patent: WO 0034279 (2000-06-01), None
Galli Frederic
Leclerc Odile
Lochead Alistair
Alexander Michael D.
Kifle Bruck
Sanofi-Synthelabo
LandOfFree
1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3371888